For the quarter ending 2026-03-31, ACAD made $268,062K in revenue. $3,637K in net income. Net profit margin of 1.36%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenues | 268,062 | 283,989 | 278,633 | 264,566 |
| Cost of product sales | 24,791 | 26,225 | 21,647 | 20,734 |
| Research and development | 76,868 | 84,757 | 87,829 | 77,951 |
| Selling, general and administrative | 171,019 | 155,616 | 133,401 | 133,507 |
| Gain on sale of non-financial asset | - | 0 | - | - |
| Total operating expenses | 272,678 | 266,598 | 242,877 | 232,192 |
| (loss) income from operations | -4,616 | 17,391 | 35,756 | 32,374 |
| Interest income, net | 8,055 | 8,332 | 8,246 | 7,243 |
| Other income | 542 | 596 | 593 | 594 |
| Income before income taxes | 3,981 | 26,319 | 44,595 | 40,211 |
| Income tax expense | 344 | -247,249 | -27,184 | 13,545 |
| Net loss | 3,637 | 273,568 | 71,779 | 26,666 |
| Basic EPS | 0.02 | 1.61 | 0.43 | 0.16 |
| Diluted EPS | 0.02 | 1.584 | 0.42 | 0.16 |
| Basic Average Shares | 170,517,000 | 169,953,000 | 168,836,000 | 167,827,000 |
| Diluted Average Shares | 172,706,000 | 172,677,000 | 170,650,000 | 168,681,000 |
ACADIA PHARMACEUTICALS INC (ACAD)
ACADIA PHARMACEUTICALS INC (ACAD)